Free Trial

Acelyrin (SLRN) Earnings Date, Estimates & Call Transcripts

Acelyrin logo
$2.05 -0.04 (-1.91%)
As of 03:33 PM Eastern

Acelyrin Earnings Summary

Acelyrin posted Q4 2024 earnings on March 19, 2025, reporting an EPS of -$0.79, which beat the consensus estimate of -$0.86 by $0.07. With a trailing EPS of -$2.50, Acelyrin's earnings are expected to grow next year, from ($2.53) to ($2.19) per share.

Latest Q4
Earnings Date
Mar. 19Estimated
Consensus EPS
(Mar. 19)
-$0.86
Actual EPS
(Mar. 19)
-$0.79 Beat By $0.07
Get Acelyrin Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Acelyrin and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

SLRN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Acelyrin Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251-$0.44-$0.44-$0.44
Q2 20251-$0.46-$0.46-$0.46
Q3 20251-$0.49-$0.49-$0.49
Q4 20251-$0.52-$0.52-$0.52

Acelyrin Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
3/19/2025Q4 2024-$0.86-$0.79+$0.07-$0.79--
8/13/2024Q2 2024-$0.78-$0.86 -$0.08-$0.86--
5/14/2024Q1 2024-$0.93-$0.36+$0.57-$0.36--
3/28/2024Q4 2023-$1.00-$0.75+$0.25-$0.75--
11/7/2023Q3 2023-$0.47-$0.87 -$0.40-$0.87--
8/14/2023Q2 2023-$0.81-$0.56+$0.25-$0.72--
6/15/2023Q1 2023-$0.88-$2.11 -$1.23$4.39--

Acelyrin Earnings - Frequently Asked Questions

Acelyrin (NASDAQ:SLRN) last announced its quarterly earning data on Wednesday, March 19, 2025. Learn more on SLRN's earnings history.

In the previous quarter, Acelyrin (NASDAQ:SLRN) reported ($0.79) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.86) by $0.07. Learn more on analysts' earnings estimate vs. SLRN's actual earnings.

Acelyrin (NASDAQ:SLRN) has a recorded net income of -$381.64 million. SLRN has generated -$2.50 earnings per share over the last four quarters.

Acelyrin's earnings are expected to grow from ($2.53) per share to ($2.19) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:SLRN) was last updated on 5/14/2025 by MarketBeat.com Staff
From Our Partners